Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dartmouth bioengineers develop humanized yeast

29.08.2003


Bioengineers at Dartmouth have genetically engineered yeast to produce humanized therapeutic proteins to address the manufacturing crunch currently confronting the biopharmaceutical industry. Reported in this week’s issue of Science, the researchers have re-engineered the yeast P. pastoris to secrete a complex human glycoprotein--a process offering significant advantages over current production methods using mammalian cell lines, according to the researchers.

The study, titled "Production of Complex Human Glycoproteins in Yeast," is one result of a collaboration between researchers at Dartmouth’s Thayer School of Engineering and GlycoFi, Inc., a biotech company located in Lebanon, New Hampshire. Founded in the spring of 2000 by Dartmouth engineering professors Tillman Gerngross and Charles Hutchinson, GlycoFi is advancing technology for the production of humanized proteins using fungal-based expression systems.

"For the first time, we have shown that yeast can be used to produce a complex human glycoprotein," says Professor Gerngross. "This technology has the potential to revolutionize the way therapeutic proteins are made--better, cheaper, faster, safer--and offer a level of control over the quality of the end product that has never existed before."



Proteins for pharmaceuticals must be manufactured by living cells. These cells are genetically engineered to produce (or express) proteins that mimic the ones synthesized by humans. These proteins can then be used to treat diseases ranging from cancer and multiple sclerosis to hemophelia and renal disease.

Current production of these therapeutic proteins, however, is limited by capacity due to rapid growth in the discovery of protein-based therapies--to the point that some approved drugs cannot be produced in adequate amounts, and still others are not making it into commercialization due to cost-prohibitive production methods.

"This development is very timely considering the production capacity bottleneck that’s facing today’s biomanufacturing industry," notes Hutchinson, CEO of GlycoFi and Dean Emeritus of Thayer School.

The Dartmouth researchers genetically engineered the yeast P. pastoris to perform a series of sequential reactions (pathways) that mimic the processing of proteins in humans. After eliminating non-human pathways from the yeast, five genes were inserted causing the yeast to construct a new secretion pathway that synthesizes human-like glycoprotein structures of superior quality.

"The protein structures we are seeing in our yeast are of a purity and uniformity unprecedented in biopharmaceutical manufacturing," said Stefan Wildt, Director of Strain Devlopment at GlycoFi, and one of the authors of the paper. "This makes it possible to harness both the inherent advantages of fungal protein expression systems and the potential to significantly increase pharmaceutical production capacities, therefore ultimately improving patient access to life-saving drug therapies."

Sue Knapp | EurekAlert!
Further information:
http://www.dartmouth.edu/

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>